Bonraybio Co., Ltd. (TPE:6955)
88.00
-3.60 (-3.93%)
Nov 20, 2026, 1:08 PM CST
Bonraybio Revenue
Bonraybio had revenue of 87.11M TWD in the quarter ending September 30, 2026, with 18.91% growth. This brings the company's total for the last twelve months to 346.06M, up 20.54% year-over-year. In the year 2025, Bonraybio had annual revenue of 306.31M with 37.43% growth. That makes Bonraybio the 37,206th largest company in the world by revenue and 1,948th in Taiwan.
Revenue (ttm)
346.06M
Revenue Growth
+20.54%
P/S Ratio
7.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.67B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Bonraybio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.31M | 83.43M | 37.43% |
| Dec 31, 2024 | 222.88M | 63.24M | 39.61% |
| Dec 31, 2023 | 159.64M | 53.37M | 50.22% |
| Dec 31, 2022 | 106.27M | 49.98M | 88.78% |
| Dec 31, 2021 | 56.30M | 29.71M | 111.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hi-Clearance | 4.51B |
| InnoCare Optoelectronics | 3.07B |
| Wellell | 2.56B |
| Apex Biotechnology | 1.86B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| WeLeader Biomedical | 1.27B |
| A Plus Biotechnology | 919.38M |